We are live on ! Find out more
Axa

Axa Portfolio holdings

AUM $91.9M
1-Year Est. Return 27.41%
This Fund
S&P 500
This Quarter Est. Return
+9.24%
1 Year Est. Return
+27.41%
3 Year Est. Return
+100.68%
5 Year Est. Return
+129.89%
10 Year Est. Return
+554.73%
AUM
$27.7B
AUM Growth
+$2.29B
Cap. Flow
+$341M
Cap. Flow %
1.23%
Top 10 Hldgs %
18.59%
Holding
1,249
New
118
Increased
427
Reduced
427
Closed
119

Top Buys

Rank Stock Value
1
TSLA icon
Tesla
TSLA
+$113M
2
AAPL icon
Apple
AAPL
+$69M
3
PFE icon
Pfizer
PFE
+$57M
4
VZ icon
Verizon
VZ
+$50.4M
5
MSFT icon
Microsoft
MSFT
+$48.6M

Top Sells

Rank Stock Value
1
ORCL icon
Oracle
ORCL
+$100M
2
LIN icon
Linde
LIN
+$85.1M
3
ABMD
Abiomed Inc
ABMD
+$55.4M
4
RACE icon
Ferrari
RACE
+$51.7M
5
BRK.B icon
Berkshire Hathaway Class B
BRK.B
+$44.1M

Sector Composition

Rank Sector Weight
1 Technology 27.12%
2 Healthcare 20.97%
3 Financials 10.86%
4 Consumer Discretionary 10.19%
5 Industrials 8.84%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GE icon
426
GE Aerospace
GE
$325B
$10.1M 0.04%
247,086
-25,679
-9% -$1.26M
EYE icon
427
National Vision
EYE
$1.3B
$10.1M 0.04%
259,587
-6,643
-2% -$249K
SO icon
428
Southern Company
SO
$99.2B
$9.98M 0.04%
139,776
-35,695
-20% -$2.39M
CXM icon
429
Sprinklr
CXM
$1.3B
$9.92M 0.04%
1,213,902
-25,128
-2% -$218K
MET icon
430
MetLife
MET
$61.8B
$9.9M 0.04%
136,797
-62,999
-32% -$4.51M
PAGS icon
431
PagSeguro Digital
PAGS
$2.61B
$9.82M 0.04%
1,123,518
-49,804
-4% -$585K
INCY icon
432
Incyte
INCY
$25.3B
$9.79M 0.04%
121,905
-862
-0.7% -$66K
SLN
433
Silence Therapeutics
SLN
$777M
$9.79M 0.04%
641,666
RHI icon
434
Robert Half
RHI
$3.8B
$9.71M 0.04%
131,553
-10,845
-8% -$827K
WU icon
435
Western Union
WU
$2.04B
$9.63M 0.03%
699,190
-276,316
-28% -$3.82M
DVA icon
436
DaVita
DVA
$12.4B
$9.63M 0.03%
+128,928
New +$10M
STOR
437
DELISTED
STORE Capital Corporation
STOR
$9.59M 0.03%
299,080
-248,777
-45% -$7.89M
PNR icon
438
Pentair
PNR
$9.01B
$9.54M 0.03%
212,079
-307,816
-59% -$13.4M
SLF icon
439
Sun Life Financial
SLF
$44.6B
$9.52M 0.03%
205,180
-265,480
-56% -$11.7M
KHC icon
440
The Kraft Heinz Company
KHC
$29.3B
$9.5M 0.03%
233,438
+187,094
+404% +$7.1M
WEX icon
441
WEX
WEX
$6.72B
$9.42M 0.03%
57,576
-3,866
-6% -$602K
TFC icon
442
Truist Financial
TFC
$59.2B
$9.42M 0.03%
218,952
-70,057
-24% -$3.07M
MANH icon
443
Manhattan Associates
MANH
$12.4B
$9.29M 0.03%
76,500
+300
+0.4% +$36.9K
HZNP
444
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
$9.24M 0.03%
81,233
-122,247
-60% -$10.2M
RMBS icon
445
Rambus
RMBS
$8.83B
$9.22M 0.03%
257,269
+155,069
+152% +$5.24M
IQV icon
446
IQVIA
IQV
$44.2B
$9.12M 0.03%
44,532
+92
+0.2% +$18.7K
BMO icon
447
Bank of Montreal
BMO
$120B
$9.1M 0.03%
100,410
-71,920
-42% -$6.66M
ZLAB icon
448
Zai Lab
ZLAB
$2.77B
$9.1M 0.03%
296,306
+40,613
+16% +$1.28M
ATKR icon
449
Atkore
ATKR
$3.19B
$9.07M 0.03%
80,000
+18,500
+30% +$1.94M
CAG icon
450
Conagra Brands
CAG
$7.29B
$8.93M 0.03%
+230,807
New +$8.37M

Similar funds

Axa's Q4 2022 Portfolio in Review

As of Q4 2022, Axa held 1,249 positions worth $27.7B, up 9% from $25.4B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Axa's Q4 2022 filing shows 118 new, 427 increased, 427 reduced and 119 closed positions. Its largest new stake was Vanguard S&P 500 ETF: 119,000 shares worth $41.8M. The largest sale was Oracle, an estimated $100M.

By sector, the portfolio is most concentrated in Technology at 27% of assets, down from 28% a quarter earlier, followed by Healthcare and Financials.

  • Axa's largest Q4 2022 buy was Vanguard S&P 500 ETF: 119,000 shares worth $41.8M.
  • Axa added most to Tesla in Q4 2022, an estimated $113M increase.
  • Axa's biggest Q4 2022 reduction was Oracle, cutting an estimated $100M.
  • Axa fully exited Abiomed Inc in Q4 2022, selling an estimated $55.4M.
  • Axa's ten largest holdings make up 19% of its $27.7B portfolio in Q4 2022.
  • Axa opened 118 new positions and closed 119 in Q4 2022.
  • Axa's portfolio value rose 9% quarter-over-quarter to $27.7B.

Based on Axa's 13F filing for Q4 2022, filed 14 Feb 2023.